24.03.2023 20:52:08

Why Shares of Orchestra BioMed Jumped This Week

Shares of Orchestra BioMed Holdings (NASDAQ: OBIO) were up 26% for the week as of Friday afternoon, according to data provided by S&P Global Market Intelligence. The healthcare stock closed at $12.18 last Friday and rose to as high as $17.43 on Tuesday. Orchestra BioMed has a 52-week low of $7.49 and a 52-week high of $19.18.The medical device technology company went public via a special purpose acquisition company merger (SPAC) on Jan. 26 and is up more than 54% since it began trading. The stock rose a day after the global market intelligence company Tracxn named Orchestra BioMed to its list of top cardiac and vascular disorders start-ups.The medical device company focuses on partnerships with medical device companies, helping them to develop new products. Its revenue will come from royalties payments, as well as double-digit revenue sharing from its products. It has a strategic partnership with Medtronic to help develop BackBeat Cardiac Neuromodulation Therapy, a potential hypertension treatment for patients with cardiac pacemakers.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Nachrichten zu Orchestra BioMed Holdings Inc Registered Shsmehr Nachrichten

Analysen zu Orchestra BioMed Holdings Inc Registered Shsmehr Analysen

Eintrag hinzufügen

Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Orchestra BioMed Holdings Inc Registered Shs 15,73 -0,01% Orchestra BioMed Holdings Inc Registered Shs